The country represented 10% of the Asia-Pacific market in 2024. India’s transcatheter mitral valve repair (TMVR) market is ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...

According to GlobalData’s Innovation Radar report, “AI Chips – Trends, Market Dynamics and Innovations,” the global AI chip ...

The deal positions South Korea as a reliable source of modern military equipment compatible with Nato standards.

The US dominates overall sales, yet GlobalData predicts that China is shaping up to be a formidable presence in the cell therapy space.

As the world increasingly shifts toward sustainable energy, demand for specialised insurance products tailored to the unique ...

The construction sector is recognising the potential of AI to revolutionise processes across the project lifecycle ...

CKD anemia market to hit $5.3B by 2034, fueled by HIF-PH inhibitor innovation, despite rising generic competition and ...

The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the ...

While progress on the Trump tariffs is being made, “the underlying drivers of de-globalisation are inexorable.” ...

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) ...

Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice.